Healthcare

Clinical Trials / Studies

Master
Content

Clinical trials - also known as clinical studies or research protocols - are conducted to test whether a new drug, new prevention strategy, or new screening test is safe and effective in people. Participation is always voluntary. Baylor College of Medicine investigators conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions.

Content

View Actively Recruiting Studies at Baylor College of Medicine trials on ClinicalTrials.gov.

Search for Clinical Trials

Utilization of a Mindfulness Smartphone Application Among High Risk Pregnant Women to Reduce Perceived Stress and Improve Other Markers of Mental…
  • Obstetrics and Gynecology
A multicenter, double-masked, randomized, vehicle-controlled 12-month (with a 12-month, double-masked extension) parallel comparison of the safety…
  • Eye and Vision
ROMA:WOMEN is a prospective un-blinded randomized multicenter clinical trial. Patients will be randomized to a single arterial graft (SAG) or…
  • Heart
Abbvie Inc. - An Open-label extension of studies M15-736 and M20-339 to evaluate the safety and tolerability of 24-hour daily exposure of Abbv-951 in…
  • Neurovascular
A multicenter, open-label, study to evaluate the long-term safety of ecopipam tablets in children, adolescents and adults with Tourette's disorderThe…
  • Neurovascular
Sage Therapeutics, Inc. is sponsoring this study of an investigational drug called SAGE-718.  SAGE-718 is being evaluated for possible…
  • Neurovascular
A multicenter, double-blind, placebo-controlled, randomized withdrawal study to evaluate the safety and maintenance of efficacy of ecopipam in…
  • Neurovascular
A 17-Week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, multicenter study of the efficacy and safety of…
  • Neurovascular
The purpose of this study is to find out how safe and effective the new drug, AMX0035, is for the treatment of PSP and to determine if AMX0035 can…
  • Neurovascular
IKT-148009-201/ A Phase 2, randomized, double-blind, placebo-controlled trial of IKT-148009 in untreated Parkinson's diseaseThe purpose of this study…
  • Neurovascular